Investors/Media

FAQs

Show All
What does Spruce Biosciences do?

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH). The company also plans to evaluate tildacerfont in pediatric classic CAH and polycystic ovary syndrome.

On what exchange does Spruce Biosciences trade, and what is the ticker symbol?

Spruce Biosciences trades on the Nasdaq Global Market under the symbol “SPRB”.

Where is Spruce Biosciences headquartered?

Spruce Biosciences’ headquarters are located at 2001 Junipero Serra Boulevard, Suite 640, Daly City, CA 94014.

Who are members of Spruce Biosciences’ Board of Directors?

The biographies of Spruce Biosciences’ directors are available in the “Board of Directors” section of our company website here.

Who are members of Spruce Biosciences’ management team?

The biographies of Spruce Biosciences’ management are available in the “Management Team” section of our company website here.

When does Spruce Biosciences’ fiscal year end?

Spruce Biosciences’ fiscal year ends December 31st.

Who are Spruce Biosciences’ independent registered public accountants?

Spruce Biosciences’ independent auditor for the fiscal year ended December 31, 2020 is BDO LLP.

Address:
300 Park Avenue, Suite 900
San Jose, CA 95110

Phone: 408-278-0220

Who is Spruce Biosciences’ outside counsel?

Spruce Biosciences’ outside legal counsel is Cooley LLP.

Address:
101 California Street
5th Floor
San Francisco, CA 94111-5800

Phone: (415) 693-2000

How do I obtain a copy of Spruce Biosciences’ SEC filings?

Spruce Biosciences’ quarterly and annual reports and other SEC filings are available by selecting the “SEC Filings” section of our “Investors” page on our company website here, or through SEC’s website here.

What is Spruce Biosciences’ CUSIP number?

Spruce Biosciences’ CUSIP number is 85209E 109.

Who is Spruce Biosciences’ transfer agent?

Computershare
USA +1 (800) 736-3001
(US, Canada, Puerto Rico)
+1 (781) 575 3100 (non-US)
web.queries@computershare.com

Shareholder Correspondence should be mailed to:
Computershare
P.O. Box 505000
Louisville, KY 40233

Shareholder Overnight correspondence should be sent to:
Computershare
462 South 4th Street, Suite 1600
Louisville, KY 40202

When is your next earnings release?

Please see the "Events & Presentations" section of our company website here for a listing of upcoming earnings announcements and other key events.

How do I contact Spruce Biosciences’ Investor Relations?

You can contact Spruce Biosciences’ Investor Relations via email by clicking here.

How do I contact Spruce Biosciences’ Media Relations?

You can contact Spruce Biosciences’ Media Relations via email by clicking here.

Where and when was Spruce Biosciences incorporated?

Spruce Biosciences was incorporated in Delaware in April 2016.

How can I update my stockholder information for an address or name change?

If your shares are held in street name (by your broker), you must notify the securities firm holding your stock. If you hold stock certificates in your own name, address changes should be submitted in writing via U.S. mail to our transfer agent, Computershare:

For written requests by regular mail:
Computershare
P.O. Box 505000
Louisville, KY 40233

For written requests by overnight delivery:
Computershare
462 South 4th Street, Suite 1600
Louisville, KY 40202